List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
9785-CL-0003A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects with Prostate Cancer English


English


9785-CL-0007A Phase I open-label study to evaluate the effect of multiple doses of MDV3100 (ASP9785) on the pharmacokinetics of substrates for CYP2C8, CYP2C9, CYP2C19, and CYP3A4 in patients with castration-resistant prostate cancer English


English


9785-CL-0011A Phase 2 Study Determining Safety and Tolerability of Enzalutamide (formerly MDV3100) in Combination with Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients English


English


9785-CL-0111A Phase 1-2, Open-Label, Uncontrolled, Dose-Escalation Study of MDV3100 in Patients with Castration-Resistant Prostate Cancer English


English


NextLast

QUICK SEARCH

USEFUL LINKS